[PDF] Top 20 Los trabajadores portuarios en Mar del Plata
Has 10000 "Los trabajadores portuarios en Mar del Plata" found on our website. Below are the top 20 most common "Los trabajadores portuarios en Mar del Plata".
Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
... of colorectal and other cancers [55] and aflibercept (VEGF Trap, known in the US as ziv-aflibercept), is a recombinant fusion protein with receptor components of VEGFR-1 and VEGFR-2 that binds multiple ligands in ... See full document
5
Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer
... of targeted therapy and no studies evaluated the activity of bevacizumab as a rechallenge therapy (both as a monotherapy or in combination with standard chemotherapy) so ...that targeted ... See full document
52
The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer
... oral therapy, although never reaching an NCI CTC grade to cause alarm, may impact as much or more on quality of life as the severe but short-lived toxicities of cyclical intravenous ... See full document
39
Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review
... Comprehensive Cancer Network ...of therapy, patient 1 showed 4 months of PFS, and patient 2 gained significant efficacy with 10 months of ...clinical benefits of VEGF ... See full document
6
Biomarkers predicting resistance to epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer with wild-type KRAS
... this therapy, a considerable proportion of patients with wild-type KRAS have no response to the ...KRAS colorectal cancer patients, can identify more patients unlikely to respond to anti-EGFR ... See full document
24
Treatment Patterns and Economic Assessment of Systemic Therapy for Metastatic Colorectal Cancer
... for metastatic CRC (mCRC) has increased in re- cent years, providing new combination chemotherapy and targeted therapy options [3] and improved overall ...stage cancer. National organizations ... See full document
54
Personalized treatment for advanced colorectal cancer: KRAS and beyond
... of targeted therapies for colorectal cancer (CRC) has brought the potential to prescribe therapy for the specific abnormalities within an individual tumor and hence personalize ... See full document
109
Relationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancer
... tumor-driven angiogenesis pathway through the abnormal activation of HIF-1α is well ...metabolism, angiogenesis, cell survival and ...tumor angiogenesis and of worse prognosis [105, ... See full document
120
First-line targeted therapies in the treatment of metastatic colorectal cancer – role of cetuximab
... Worldwide, colorectal cancer (CRC) is the fourth most commonly diagnosed malignant disease and the second leading cause of cancer-related death in Western ...New targeted therapies, including ... See full document
35
Molecularly targeted drugs for metastatic colorectal cancer
... with metastatic colorectal cancer (mCRC) has significantly improved with applications of molecularly targeted drugs, such as bevacizumab, and led to a substantial improvement in the overall ... See full document
16
Targeted alpha anticancer therapies: update and future prospects
... Labeling cancer targeting antibodies with a toxin can potentiate antibody efficacy in tumor control. In this way the antibody becomes an invaluable targeting vector for delivery of the toxin to the cancer ... See full document
47
Recent developments and translational aspects in targeted therapy for metastatic breast cancer
... novel targeted therapies in luminal BC is therefore ongoing and inter- est in this fi eld has recently focused on ...endocrine therapy over endocrine therapy alone in the BELLE-2 trial, this effect ... See full document
16
ANGIOGENESIS AND CANCER THERAPY
... human cancer 25, 26, and 27 . A high level of VEGF-A in cancer patients serum is generally considered as unfavorable clinical parameter which indicates disease progression, lack of response to ... See full document
19
Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment
... and Therapy is an international, peer-reviewed open access journal focusing on the immunological basis of diseases, potential targets for immune based therapy and treatment protocols employed to improve ... See full document
5
Bevacizumab in the therapy for refractory metastatic colorectal cancer
... population, colorectal cancer (CRC) is the fourth most common cause of cancer and the second most common cause of cancer ...active therapy in the adjuvant and advanced disease ... See full document
61
Phase II study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metastatic colorectal cancer
... standard first-line chemotherapeutic regimens for the treatment of patients with metastatic colorectal cancer (mCRC) [2–4]. However, the FOLFOX and FOLFIRI regimens are less desirable because 5-FU ... See full document
27
Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)
... domized to receive either an OPTIMOX1 approach or an induction FOLFOX regimen followed by discontinuation of all chemotherapy until tumor progression reached base- line, followed by reintroduction of FOLFOX. Results of ... See full document
42
Quality of life during first-line FOLFOX4±panitumumab in RAS wild-type metastatic colorectal carcinoma: results from a randomised controlled trial
... The QoL scales used in these studies, including the EQ-5D, are measures of global QoL and are not speci fi c for skin toxicity. In patients treated with panitumumab in the PRIME study, therefore, the impact of ... See full document
15
Does antithrombotic therapy improve survival with colorectal cancer?
... of cancer recurrence and improves survival [13, ...platelet therapy may result in an increased incidence of solid cancers ...antiplatelet therapy may inhibit tumor ...antithrombotic therapy ... See full document
13
Comparison between three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer
... the Cancer Institute Hospital of the Japanese Foundation for Cancer Research in ...other metastatic sites was almost similar when comparing the three ... See full document
8
Related subjects